Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100747372 | 10074737 | 2 | F | 201312 | 20140915 | 20140414 | 20140930 | PER | US-BIOGENIDEC-2014BI031952 | BIOGEN | 65.00 | YR | E | F | Y | 0.00000 | 20140930 | N | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100747372 | 10074737 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | INTRAVENOUS | D | 125104 | 300 | MG | INTRAVENOUS INFUSION | /month | ||||||
| 100747372 | 10074737 | 2 | C | ESTRACE | ESTRADIOL | 1 | D | 0 | 0 | MG | |||||||||
| 100747372 | 10074737 | 3 | C | FABRAZYME | AGALSIDASE BETA | 1 | INTRAVENOUS | D | 0 | 60 | MG | QOW | |||||||
| 100747372 | 10074737 | 4 | C | LYRICA | PREGABALIN | 1 | ORAL | D | 0 | 150 | MG | BID | |||||||
| 100747372 | 10074737 | 5 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | ORAL | D | 0 | 17 | G | QD | |||||||
| 100747372 | 10074737 | 6 | C | MUCINEX | GUAIFENESIN | 1 | ORAL | D | 0 | 1200 | MG | BID | |||||||
| 100747372 | 10074737 | 7 | C | THERMOTABS | 2 | ORAL | D | 0 | TABLET | TID | |||||||||
| 100747372 | 10074737 | 8 | C | TYLENOL | ACETAMINOPHEN | 1 | ORAL | D | 0 | 750 | MG | ||||||||
| 100747372 | 10074737 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | ORAL | D | 0 | 1000 | MG | ||||||||
| 100747372 | 10074737 | 10 | C | XANAX | ALPRAZOLAM | 1 | ORAL | D | 0 | 1 | MG | ||||||||
| 100747372 | 10074737 | 11 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | ORAL | D | 0 | 150 | MG | ||||||||
| 100747372 | 10074737 | 12 | C | CALCIUM-VITAMIN D | 2 | ORAL | D | 0 | TABLET | ||||||||||
| 100747372 | 10074737 | 13 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | TOPICAL | D | 0 | BIW | |||||||||
| 100747372 | 10074737 | 14 | C | MAGNESIUM CITRATE. | MAGNESIUM CITRATE | 1 | ORAL | D | 0 | 399 | MG | ||||||||
| 100747372 | 10074737 | 15 | C | OXYCODONE | OXYCODONE | 1 | ORAL | D | 0 | 10 | MG | Q3H | |||||||
| 100747372 | 10074737 | 16 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | ORAL | D | 0 | 8 | MEQ | ||||||||
| 100747372 | 10074737 | 17 | C | PSYLLIUM | PLANTAGO SEED | 1 | ORAL | D | 0 | CAPSULE | |||||||||
| 100747372 | 10074737 | 18 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | ORAL | D | 0 | 150 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100747372 | 10074737 | 1 | Multiple sclerosis |
| 100747372 | 10074737 | 3 | Fabry's disease |
| 100747372 | 10074737 | 10 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100747372 | 10074737 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100747372 | 10074737 | Hyponatraemia | |
| 100747372 | 10074737 | Petechiae | |
| 100747372 | 10074737 | Pneumonia aspiration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100747372 | 10074737 | 1 | 20131018 | 0 |